The safety committee of the European Medicines Agency (EMA) has found that the Oxford-AstraZeneca Covid-19 vaccine can cause unusual blood clots with low blood platelets, but stresses the overall benefits of the vaccine in preventing coronavirus outweigh the risks of side effects.
Top Investments for 2025: A Focus on the S&P 500
As we move into 2025, the S&P 500 continues to be a cornerstone of investment strategies, offering insights into the U.S. stock market’s health. Following
